Another recent evidence in SCLC demonstrates that HMGB1 promotes chemoresistance by driving PARP1 PARylation and nucleophagy (a selective autophagy type), thereby removing PARP1 from DNA lesions and allowing persistent repair evasion [33]. Here, PARP1 is linked to small cell lung carcinoma.